At the European summit on Thursday, March 25, the Twenty-Seven called for more firmness vis-à-vis laboratories that did not respect their commitments.
As expected, the Twenty-Seven recalled, Thursday March 25 at a European summit, the importance of being more vigilant on the exports of vaccines manufactured on European soil with a country in sight: the United Kingdom . One laboratory has been targeted: AstraZeneca. During this summit, the President of the European Commission, Ursula von der Leyen, came up with quite edifying figures: since the beginning of December, the United Kingdom has imported more than 20 million vaccines from Europe, without providing a single one. dose in the other direction while two AstraZeneca factories exist on its soil.
The objective is not to start a war with London, confides a politician, but to build a balance of power: the United Kingdom needs vaccines to provide a second dose to its population. By implementing these controls, the Europeans want to ensure that AstraZeneca factories located in Europe supply Europeans as a priority. Discussions are underway between London and Brussels to find a common solution, explains France Televisions journalist Julien Gasparutto.